132 related articles for article (PubMed ID: 37295604)
1. Comparison of the Protective Effect of Polysorbates, Poloxamer and Brij on Antibody Stability Against Different Interfaces.
Zürcher D; Caduff S; Aurand L; Capasso Palmiero U; Wuchner K; Arosio P
J Pharm Sci; 2023 Nov; 112(11):2853-2862. PubMed ID: 37295604
[TBL] [Abstract][Full Text] [Related]
2. Protein-Polydimethylsiloxane Particles in Liquid Vial Monoclonal Antibody Formulations Containing Poloxamer 188.
Grapentin C; Müller C; Kishore RSK; Adler M; ElBialy I; Friess W; Huwyler J; Khan TA
J Pharm Sci; 2020 Aug; 109(8):2393-2404. PubMed ID: 32194095
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Properties of Novel Excipient Suggest Mechanism for Improved Performance in Liquid Stabilization of Protein Biologics.
Katz JS; Nolin A; Yezer BA; Jordan S
Mol Pharm; 2019 Jan; 16(1):282-291. PubMed ID: 30495962
[TBL] [Abstract][Full Text] [Related]
4. High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations.
Zegota MM; Schuster G; De Pra M; Müllner T; Menzen T; Steiner F; Hawe A
J Chromatogr A; 2024 Apr; 1720():464777. PubMed ID: 38432108
[TBL] [Abstract][Full Text] [Related]
5. Adsorption and Aggregation of Monoclonal Antibodies at Silicone Oil-Water Interfaces.
Kannan A; Shieh IC; Negulescu PG; Chandran Suja V; Fuller GG
Mol Pharm; 2021 Apr; 18(4):1656-1665. PubMed ID: 33656340
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of polysorbate 20 and poloxamer 188 in biopharmaceutical formulations using evaporative light scattering detection.
Paschen CA; Klemm D; Graf T; Kopf R; Pinto C; Müller C; Bell CH; Pfaff J
J Pharm Biomed Anal; 2021 Jan; 192():113640. PubMed ID: 33002754
[TBL] [Abstract][Full Text] [Related]
7. Surfactant Impact on Interfacial Protein Aggregation and Utilization of Surface Tension to Predict Surfactant Requirements for Biological Formulations.
Vargo KB; Stahl P; Hwang B; Hwang E; Giordano D; Randolph P; Celentano C; Hepler R; Amin K
Mol Pharm; 2021 Jan; 18(1):148-157. PubMed ID: 33253579
[TBL] [Abstract][Full Text] [Related]
8. Poloxamer 188 as surfactant in biological formulations - An alternative for polysorbate 20/80?
Bollenbach L; Buske J; Mäder K; Garidel P
Int J Pharm; 2022 May; 620():121706. PubMed ID: 35367584
[TBL] [Abstract][Full Text] [Related]
9. Effect of Surfactants on Mechanical, Thermal, and Photostability of a Monoclonal Antibody.
Agarkhed M; O'Dell C; Hsieh MC; Zhang J; Goldstein J; Srivastava A
AAPS PharmSciTech; 2018 Jan; 19(1):79-92. PubMed ID: 28770529
[TBL] [Abstract][Full Text] [Related]
10. Existence of a superior polysorbate fraction in respect to protein stabilization and particle formation?
Diederichs T; Mittag JJ; Humphrey J; Voss S; Carle S; Buske J; Garidel P
Int J Pharm; 2023 Mar; 635():122660. PubMed ID: 36740078
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Protein Stabilizing Capability of Surfactants Against Agitation Stress and the Underlying Mechanisms.
Zoeller MP; Hafiz S; Marx A; Erwin N; Fricker G; Carpenter JF
J Pharm Sci; 2022 Dec; 111(12):3261-3274. PubMed ID: 36096287
[TBL] [Abstract][Full Text] [Related]
12. Linking aggregation and interfacial properties in monoclonal antibody-surfactant formulations.
Kannan A; Shieh IC; Fuller GG
J Colloid Interface Sci; 2019 Aug; 550():128-138. PubMed ID: 31055138
[TBL] [Abstract][Full Text] [Related]
13. A Nanoparticle-Based Assay To Evaluate Surface-Induced Antibody Instability.
Kopp MRG; Capasso Palmiero U; Arosio P
Mol Pharm; 2020 Mar; 17(3):909-918. PubMed ID: 31917582
[TBL] [Abstract][Full Text] [Related]
14. An accelerated surface-mediated stress assay of antibody instability for developability studies.
Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P
MAbs; 2020; 12(1):1815995. PubMed ID: 32954930
[TBL] [Abstract][Full Text] [Related]
15. Brij-58, a potential injectable protein-stabilizer used in therapeutic protein formulation.
Yue L; Yan Z; Li H; Liu X; Sun P
Eur J Pharm Biopharm; 2020 Jan; 146():73-83. PubMed ID: 31811896
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.
Tomlinson A; Zarraga IE; Demeule B
Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382
[TBL] [Abstract][Full Text] [Related]
17. Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.
Gerhardt A; Mcumber AC; Nguyen BH; Lewus R; Schwartz DK; Carpenter JF; Randolph TW
J Pharm Sci; 2015 Dec; 104(12):4056-4064. PubMed ID: 26413998
[TBL] [Abstract][Full Text] [Related]
18. Differential Surface Adsorption Phenomena for Conventional and Novel Surfactants Correlates with Changes in Interfacial mAb Stabilization.
Kanthe AD; Carnovale MR; Katz JS; Jordan S; Krause ME; Zheng S; Ilott A; Ying W; Bu W; Bera MK; Lin B; Maldarelli C; Tu RS
Mol Pharm; 2022 Sep; 19(9):3100-3113. PubMed ID: 35882380
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Influence of Polysorbate 20/80 and Polaxomer P188 on the Surface & Interfacial Properties of Bovine Serum Albumin and Lysozyme.
Begum F; Amin S
Pharm Res; 2019 May; 36(7):107. PubMed ID: 31111248
[TBL] [Abstract][Full Text] [Related]
20. Combined Effect of Shaking Orbit and Vial Orientation on the Agitation-Induced Aggregation of Proteins.
Dasnoy S; Illartin M; Queffelec J; Nkunku A; Peerboom C
J Pharm Sci; 2024 Mar; 113(3):669-679. PubMed ID: 37611666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
